NuVasive shares jumped 10 percent yesterday. Here's why, according to Motley Fool.
Spinal Tech
ISTO Technologies recently received a Small Business Innovation Research grant from the National Institutes of Health.
Histogenics appointed Stephen Kennedy as chief technology officer, effective immediately.
Smith & Nephew, a global medical technology business, appointed Robin Freestone to its board as non-executive director and member of the audit committee.
Health Care Service Corp., the nation's largest customer-owned health insurer, will collaborate with MATTER, a Chicago health technology incubator.
Valence Health, a clinical integration, population health and value-based care solutions provider, named Andrew Eckert CEO. He will start his new position on Aug. 3.
Carl Lauryssen, MD, a spine surgeon with NeuroTexas, will be co-principal investigator of the study for the M6-C Artificial spinal disc at Lakeway Regional Medical Center.
Teleflex, a global provider of medical devices for critical care and surgery, signed a group purchasing agreement with HealthTrust.
NuVasive reported increased revenue for the second quarter of 2015.
Exactech reported $3.7 million in net income for the second quarter of 2015.
